Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

deseret biologicals, inc. - dibasic potassium phosphate (unii: ci71s98n1z) (phosphate ion - unii:nk08v8k8hr), ambergris (unii: xtc0d02p6c) (ambergris - unii:xtc0d02p6c), cocoa (unii: d9108tz9kg) (cocoa - unii:d9108tz9kg), lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn), arnica montana (unii: o80ty208zw) (arnica montana - unii:o80ty208zw), aconitum napellus (unii: u0nq8555jd) (aconitum napellus - unii:u0nq8555jd), oyster shell calcium - dibasic potassium phosphate 3 [hp_x] in 1 ml - for the temporary relief of symptoms of stress such as terror, horror, post traumatic stress, fight or flight response, recurring nightmares, difficulty sleeping, difficulty concentrating, restlessness, and easy irritability.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for the temporary relief of symptoms of stress such as terror, horror, post traumatic stress, fight or flight response, recurring nightmares, difficulty sleeping, difficulty concentrating, restlessness, and easy irritability.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - methylphenidate hydrochloride, quantity: 54 mg - tablet, modified release - excipient ingredients: sodium chloride; phosphoric acid; stearic acid; iron oxide yellow; carnauba wax; povidone; polyethylene oxide; cellulose acetate; hypromellose; iron oxide black; succinic acid; butylated hydroxytoluene; poloxamer; iron oxide red; titanium dioxide; lactose monohydrate; triacetin; propylene glycol; isopropyl alcohol; purified water; macrogol 400 - concerta is indicated for the treatment of attention deficit hyperactivity disorder (adhd). treatment should be commenced by a specialist.,a diagnosis of attention deficit hyperactivity disorder (adhd; dsm-iv) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years.,need for comprehensive treatment programme concerta is indicated as an integral part of a total treatment program for adhd that may include other measures (psychological, educational and social) for patients with this syndrome. stimulants are not intended for use in the patient who exhibits symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. appropriate educational placement is essential and psychosocial intervention is often helpful. when remedial measures alone are insufficient, the decision to prescribe stimulant medication will depend upon the physician?s assessment of the chronicity and severity of the patient?s symptoms.,long term use the effectiveness of concerta for long-term use has not been systematically evaluated in controlled trials. therefore the physician who elects to use concerta for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - methylphenidate hydrochloride, quantity: 36 mg - tablet, modified release - excipient ingredients: stearic acid; poloxamer; polyethylene oxide; butylated hydroxytoluene; iron oxide black; iron oxide yellow; phosphoric acid; cellulose acetate; hypromellose; succinic acid; carnauba wax; sodium chloride; povidone; titanium dioxide; lactose monohydrate; triacetin; macrogol 400; propylene glycol; isopropyl alcohol; purified water - concerta is indicated for the treatment of attention deficit hyperactivity disorder (adhd). treatment should be commenced by a specialist.,a diagnosis of attention deficit hyperactivity disorder (adhd; dsm-iv) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years.,need for comprehensive treatment programme concerta is indicated as an integral part of a total treatment program for adhd that may include other measures (psychological, educational and social) for patients with this syndrome. stimulants are not intended for use in the patient who exhibits symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. appropriate educational placement is essential and psychosocial intervention is often helpful. when remedial measures alone are insufficient, the decision to prescribe stimulant medication will depend upon the physician?s assessment of the chronicity and severity of the patient?s symptoms.,long term use the effectiveness of concerta for long-term use has not been systematically evaluated in controlled trials. therefore the physician who elects to use concerta for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - methylphenidate hydrochloride, quantity: 18 mg - tablet, modified release - excipient ingredients: iron oxide yellow; sodium chloride; povidone; butylated hydroxytoluene; iron oxide black; stearic acid; polyethylene oxide; cellulose acetate; succinic acid; phosphoric acid; hypromellose; carnauba wax; poloxamer; macrogol 400; titanium dioxide; lactose monohydrate; triacetin; propylene glycol; isopropyl alcohol; purified water - concerta is indicated for the treatment of attention deficit hyperactivity disorder (adhd). treatment should be commenced by a specialist.,a diagnosis of attention deficit hyperactivity disorder (adhd; dsm-iv) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years.,need for comprehensive treatment programme concerta is indicated as an integral part of a total treatment program for adhd that may include other measures (psychological, educational and social) for patients with this syndrome. stimulants are not intended for use in the patient who exhibits symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. appropriate educational placement is essential and psychosocial intervention is often helpful. when remedial measures alone are insufficient, the decision to prescribe stimulant medication will depend upon the physician?s assessment of the chronicity and severity of the patient?s symptoms.,long term use the effectiveness of concerta for long-term use has not been systematically evaluated in controlled trials. therefore the physician who elects to use concerta for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

king bio inc. - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh), antimony trisulfide (unii: f79059a38u) (antimony trisulfide - unii:f79059a38u), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn), phosphorus (unii: 27ylu75u4w) (phosphorus - unii:27ylu75u4w), pine tar (unii: yfh4wc535j) (pine tar - unii:yfh4wc535j), selenium (unii: h6241uj - uses for temporary relief of: dry, irritated, itchy or flaking scalp, dandruff, oily or dry hair, rough, brittle or ingrown nails. uses  ​for temporary relief of: - dry, irritated, itchy or flaking scalp - dandruff - oily or dry hair - rough, brittle or ingrown nails

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

hyland's - potassium phosphate, dibasic (unii: ci71s98n1z) (phosphate ion - unii:nk08v8k8hr), daphne mezereum bark (unii: x2n6e405gv) (daphne mezereum bark - unii:x2n6e405gv), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn), sepia officinalis juice (unii: qdl83wn8c2) (sepia officinalis juice - unii:qdl83wn8c2), delphinium staphisagria seed (unii: 00543ap1jv) (delphinium staphisagria seed - unii:00543ap1jv), sulfur (unii: - temporarily relieves the symptoms of lack of energy, irritability, difficulty waking, morning and daytime drowsiness and mental lethargy.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

dna labs, inc. - barium chloride dihydrate (unii: el5gj3u77e) (barium cation - unii:v645272hln), conium maculatum whole (unii: 79g218zmb3) (conium maculatum whole - unii:79g218zmb3), arnica montana (unii: o80ty208zw) (arnica montana - unii:o80ty208zw, arnica montana root - unii:mue8y11327), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn), dibasic potassium phosphate (unii: ci71s98n1z) (phosphate ion - unii:nk08v8k8hr, potassium cation - unii:295o53k152), ferrosoferric phosphate (unii: 91gqh8i5f7) (ferrosoferric phosphate - unii:91gqh8i5f7), pork brain (unii: 466251j72g) (pork brain - unii:466251j72g) - support for the brain, poor memory.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

dna labs, inc. - quinine arsenite (unii: 42qo5p0nlm) (quinine - unii:a7v27phc7a, arsenite ion - unii:n5509x556j), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn), matricaria chamomilla (unii: g0r4ubi2zz) (matricaria chamomilla - unii:g0r4ubi2zz), citrullus colocynthis fruit pulp (unii: 23h32aoh17) (citrullus colocynthis fruit pulp - unii:23h32aoh17), mercuric chloride (unii: 53gh7mzt1r) (mercuric cation - unii:ed30fj8y42), veratrum album root (unii: qns6w5us1z) (veratrum album root - unii:qns6w5 - diarrhea.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

deseret biologicals, inc. - dibasic potassium phosphate (unii: ci71s98n1z) (phosphate ion - unii:nk08v8k8hr), ambergris (unii: xtc0d02p6c) (ambergris - unii:xtc0d02p6c), cocoa (unii: d9108tz9kg) (cocoa - unii:d9108tz9kg), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn), arnica montana (unii: o80ty208zw) (arnica montana - unii:o80ty208zw), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), sus scrofa cerebrum (unii: 4gb5dqr532) (sus scrofa cerebrum - unii:4gb5dqr532), sus scrofa adrenal gland (unii: 398iyq16yv) (sus scrofa adrenal gland - unii:398iyq16yv), lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66), aconitum napellus (unii: u0nq8555jd) (aconitum napellus - unii:u0nq8555jd), argemone mexicana (unii: 6x68976407) (argemone mexicana - unii:6x68976407), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), cicuta virosa root (unii: yea9p21s8n) (cicuta virosa root - unii:yea9p21s8n), hyoscyamus niger (unii: 4wrk2153h3) (hyoscyamus niger - unii:4wrk2153h3), strychnos ignatii seed (unii: 1nm3m2487k) (strychnos ignatii seed - unii:1nm3m2487k), lilium lancifolium whole flowering (unii: x67z2963pi) (lilium lancifolium whole flowering - unii:x67z2963pi), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), lycosa tarantula (unii: 86m454l2tt) (lycosa tarantula - unii:86m454l2tt), datura stramonium (unii: g6w4f0v8z3) (datura stramonium - unii:g6w4f0v8z3), androctonus australis venom (unii: 25imq489aw) (androctonus australis venom - unii:25imq489aw) - for the temporary relief of symptoms of stress such as terror, horror, post traumatic stress, fight or flight response, recurring nightmares, difficulty sleeping, difficulty concentrating, restlessness, and easy irritability.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for the temporary relief of symptoms of stress such as terror, horror, post traumatic stress, fight or flight response, recurring nightmares, difficulty sleeping, difficulty concentrating, restlessness, and easy irritability.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

deseret biologicals, inc. - dibasic potassium phosphate (unii: ci71s98n1z) (phosphate ion - unii:nk08v8k8hr), ambergris (unii: xtc0d02p6c) (ambergris - unii:xtc0d02p6c), cocoa (unii: d9108tz9kg) (cocoa - unii:d9108tz9kg), lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn), arnica montana (unii: o80ty208zw) (arnica montana - unii:o80ty208zw), aconitum napellus (unii: u0nq8555jd) (aconitum napellus - unii:u0nq8555jd), oyster shell calcium - for the temporary relief of symptoms of stress such as terror, horror, post traumatic stress, fight or flight response, recurring nightmares, difficulty sleeping, difficulty concentrating, restlessness, and easy irritability.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for the temporary relief of symptoms of stress such as terror, horror, post traumatic stress, fight or flight response, recurring nightmares, difficulty sleeping, difficulty concentrating, restlessness, and easy irritability.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.